Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhG-CSF in Solid Tumors Receiving Chemotherapy
NCT02805166Phase 4Completed
- Sponsor
- CSPC Baike Biopharmaceutical
- Start
- Apr 2013
- Primary completion
- Feb 2016
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 4 trial of pegylated granulocyte colony-stimulating factor in neutropenia, sponsored by CSPC Baike Biopharmaceutical. Started Apr 2013; status: completed.
02
Drugs
pegylated granulocyte colony-stimulating factor
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT02805166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805166.